First Bank & Trust’s AstraZeneca AZN Stock Holding History

First Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-54	Closed	-$7K	–	191
2022 Q2	$7K	Hold	54	–	–	﹤0.01%	351
2022 Q1	$7K	Hold	54	–	–	﹤0.01%	359
2021 Q4	$6K	Buy	54 +27	+100%	+$3.18K	﹤0.01%	368
2021 Q3	$3K	Hold	27	–	–	﹤0.01%	395
2021 Q2	$3K	Hold	27	–	–	﹤0.01%	382
2021 Q1	$3K	Hold	27	–	–	﹤0.01%	385
2020 Q4	$3K	Hold	27	–	–	﹤0.01%	371
2020 Q3	$3K	Hold	27	–	–	﹤0.01%	353
2020 Q2	$3K	Hold	27	–	–	﹤0.01%	350
2020 Q1	$2K	Sell	27 -35	-56%	-$3.29K	﹤0.01%	373
2019 Q4	$6K	Sell	62 -171	-73%	-$16.1K	﹤0.01%	336
2019 Q3	$21K	Sell	233 -137	-37%	-$11.9K	0.02%	258
2019 Q2	$31K	Sell	370 -586	-61%	-$45.9K	0.02%	238
2019 Q1	$77K	Sell	956 -9,414	-91%	-$742K	0.06%	193
2018 Q4	$787K	Sell	10,370 -5,158	-33%	-$403K	0.67%	49
2018 Q3	$1.19M	Sell	15,528 -5,960	-28%	-$451K	0.9%	35
2018 Q2	$1.51M	Sell	21,488 -6,487	-23%	-$467K	1.16%	21
2018 Q1	$1.96M	Buy	27,975 +176	+0.6%	+$12.2K	1.57%	14
2017 Q4	$1.93M	Buy	27,799 +4,502	+19%	+$304K	1.52%	16
2017 Q3	$1.58M	Buy	23,297 +1,597	+7%	+$101K	1.29%	18
2017 Q2	$1.48M	Buy	21,700 +5,189	+31%	+$339K	1.25%	21
2017 Q1	$1.03M	Buy	16,511 +4,762	+41%	+$277K	0.89%	30
2016 Q4	$642K	Buy	+11,749	New	+$667K	0.59%	45

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

First Bank & Trust's AZN Position: Q3 2022 in Review

First Bank & Trust sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 54 shares — an estimated $7K sold.

First Bank & Trust first reported a position in AZN in Q4 2016 and held it in 23 quarters. The position peaked at $1.96M in Q1 2018. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

First Bank & Trust reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
First Bank & Trust sold 54 AstraZeneca shares in Q3 2022, an estimated $7K.
First Bank & Trust first reported a position in AstraZeneca in Q4 2016 and held it in 23 quarters.
First Bank & Trust's AstraZeneca position peaked at $1.96M in Q1 2018.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.